Articles
Fenofibrates and the Prevention of Cardiovascular Risk
The significance of hypertriglyceridemia as a cardiovascular risk factor is further highlighted by its inclusion as a component of the metabolic...
Fibrates The Other Life-saving Lipid Drugs
However, statin-based interventions are unlikely to correct problems of triglycerides and HDL, whereas the use of fibrates has a stronger effect on...
Gene Variants for Obesity and Type 2 Diabetes – A Shared Aetiology?
The incidence of type 2 diabetes is rising rapidly worldwide, and there are already more than 180 million diabetic subjects. Type 2 diabetes risk...
Generalised Glucocorticoid Resistance
The gene encoding hGRα(hGR gene) is one locus on the long arm of chromosome 5 (q31.3), and consists of nine exons spanning over 150kb....
Ghrelin and Cardiovasculature
Growth hormone secretagogues (GHS) were originally devised as small synthetic compounds, either peptides or non-peptides, with the ability to...
Glucose and Glycated Haemoglobin Point-of-care Testing and Early Diagnosis of Diabetes and Pre-diabetes
Over the last few decades the prevalence of diabetes has reached epidemic proportions in western societies and is even higher in developing...
Glucose Control in the Critically Ill Patient Utilizing Computerized Intravenous Insulin Dosing
Inpatient hospital hyperglycemia is associated with increased morbidity and mortality.1,2 This is particularly true in the critically ill patient...
Glycemic Variability and the Role It Should Play in Diabetes Management and Blood Glucose Monitoring
Glycemic variability is typically measured by self-monitoring of blood glucose (SMBG),10–16 although continuous glucose monitoring (CGM) systems...
Growth Hormone Deficiency – Difficulties in Diagnosis and Management
Additionally, it can occur in association with other congenital abnormalities such as forebrain defects, optic nerve hypoplasia or cleft lip and...
Guidelines for the practice of diabetes education
DISEASE/CONDITION(S) * Type 1 diabetes mellitus * Type 2 diabetes mellitus GUIDELINE CATEGORY Counseling Evaluation Management Prevention...
Halting the Progression of Diabetic Nephropathy
Therapies that are proved to delay or prevent this outcome will clearly be of major benefitThe aetiology of DN is unknown. Hyperglycaemia is...
How Should Diabetes Be Treated to Minimize the Risk of Cardiovascular Complications?
Cardiovascular disease (CVD) and diabetes, especially type 2, are closely intertwined and growing health threats in the US and many other regions of...
Hypertension Nephropathy Complex
The condition is believed to pass through arbitrary stages of escalating albuminuria associated with a parallel rise in blood pressure and fall in...
Hypoglycaemia in Type 2 Diabetes – Clinical Consequences and Impact on Treatment
Hypoglycaemia is a common problem for many patients with diabetes and the risks and consequences need to be considered when prescribing therapy....
Hypoglycemia - The Major Barrier to Good Glycemic Control
Risk factors have been identified for iatrogenic hypoglycemia, and physiologic studies have revealed the mechanisms of many of these risk factors....
Hypoglycemia and the Central Nervous System
Hypoglycemia is not limited to patients with type 1 diabetes, but frequently occurs in patients with type 2 diabetes as well.4,5 As the ratelimiting...
Hypoglycemia The Major Barrier to Good Glycemic Control
Risk factors have been identified for iatrogenic hypoglycemia, and physiologic studies have revealed the mechanisms of many of these risk factors....
Importance of Self-care Behaviors in Diabetes Management
Diabetes is a complex disease requiring the adoption of numerous skills and behaviors in order for the disease to be managed successfully. Diabetes...
Improving Diabetes Management and Care—Is it All About the Advancement of Pharmacotherapy?
The costs associated with diabetes have been increasing since the late 1970s,with significant rises noted in the late 1990s and early 2000s, and...
Improving Glycaemic Control - A Mandatory Action Calling for Effective Therapeutic Management
Prevention of DiabetesAlong with advances in the treatment of hyperglycaemia and associated metabolic disturbances and diabetic complications, a...
- 11 September 2010
